Table 4 The relative risk of cardiovascular diseases in participants according to sex and diabetes.

From: Impact of sex and menopausal hormonal therapy on cardiovascular diseases in people with diabetes or prediabetes

 

Sex

Diabetes

Hazard

ratios

95% CI

P-value

Hazard

ratios

95% CI

P-value

Hazard

ratios

95% CI

P-value

Heart failure

Men

Prediabetes

1

        

Men

Diabetes

1.180

1.148–1.213

< 0.001

1

     

Women

Prediabetes

1.150

1.118–1.183

< 0.001

0.928

0.888–0.970

0.001

1

  

Women

Diabetes

1.357

1.293–1.424

< 0.001

1.095

1.068–1.123

< 0.001

1.124

1.096–1.153

< 0.001

Acute myocardial infarction

Men

Prediabetes

1

        

Men

Diabetes

1.201

1.162–1.241

< 0.001

1

     

Women

Prediabetes

0.330

0.315–0.347

< 0.001

0.422

0.397–0.448

< 0.001

1

  

Women

Diabetes

0.397

0.372–0.423

< 0.001

0.507

0.486–0.528

< 0.001

1.842

1.746–1.943

< 0.001

Ischemic stroke

Men

Prediabetes

1

        

Men

Diabetes

1.284

1.258–1.312

< 0.001

1

     

Women

Prediabetes

0.698

0.681–0.716

< 0.001

0.591

0.570–0.613

< 0.001

1

  

Women

Diabetes

0.897

0.863–0.932

< 0.001

0.759

0.742–0.777

< 0.001

1.396

1.361–1.433

< 0.001

Hemorrhagic stroke

Men

Prediabetes

1

        

Men

Diabetes

1.087

1.042–1.135

< 0.001

1

     

Women

Prediabetes

0.930

0.891–0.972

0.001

0.834

0.772-0.900

< 0.001

1

  

Women

Diabetes

1.011

0.942–1.087

0.755

0.906

0.863–0.951

< 0.001

1.059

1.009–1.112

0.021

Stroke

Men

Prediabetes

1

        

Men

Diabetes

1.234

1.211–1.258

< 0.001

1

     

Women

Prediabetes

0.750

0.734–0.767

< 0.001

0.638

0.617–0.660

< 0.001

1

  

Women

Diabetes

0.925

0.894–0.958

< 0.001

0.787

0.771–0.804

< 0.001

1.296

1.266–1.326

< 0.001

  1. HRs were adjusted for age, smoking status, alcohol consumption status, physical activity level, drug prescriptions for antihypertensives and lipid-lowering therapies, body mass index, and fasting glucose.
  2. CI, confidence interval.